Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Thierry Poynard
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Anatomy
Procedures
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
84
Ratziu, Vlad
46
Naveau, Sylvie
40
Imbert-Bismut, Françoise
40
Chaput, Jean-Claude
39
Charlotte, Frédéric
38
Thabut, Dominique
36
Benhamou, Yves
36
Opolon, Pierre
35
Messous, Djamila
34
Munteanu, Mona
33
Bedossa, Pierre
31
Thibault, Vincent
25
Mathurin, Philippe
18
Myers, Robert
18
Moussalli, Joseph
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Thierry Poynard (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Poynard T; Massard J; Rudler M; Varaud A; Lebray P; Moussalli J; Munteanu M; Ngo Y; Thabut D; Benhamou Y; Ratziu V
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.
Gastroentérologie clinique et biologique 2009;33(10-11):916-22.
-
2009: Friedrich-Rust Mireen; Wunder Katrin; Kriener Susanne; Sotoudeh Fariba; Richter Swantje; Bojunga Joerg; Herrmann Eva; Poynard Thierry; Dietrich Christoph F; Vermehren Johannes; Zeuzem Stefan; Sarrazin Christoph
Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.
Radiology 2009;252(2):595-604.
-
2009: Ingiliz Patrick; Chhay Kim Pav; Munteanu Mona; Lebray Pascal; Ngo Yen; Roulot Dominique; Benhamou Yves; Thabut Dominique; Ratziu Vlad; Poynard Thierry
Applicability and variability of liver stiffness measurements according to probe position.
World journal of gastroenterology : WJG 2009;15(27):3398-404.
-
2009: Zeuzem Stefan; Gane Edward; Liaw Yun-Fan; Lim Seng G; DiBisceglie Adrian; Buti Maria; Chutaputti Anuchit; Rasenack Jens; Hou Jinlin; O'Brien Christopher; Nguyen Tuan T; Jia Jidong; Poynard Thierry; Belanger Bruce; Bao Weibin; Naoumov Nikolai V
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.
Journal of hepatology 2009;51(1):11-20.
-
2009: Poynard Thierry; Benhamou Yves; Thabut Dominique; Ratziu Vlad
Liver biopsy: the best standard...when everything else fails.
Journal of hepatology 2009;50(6):1267-8.
-
2009: Poynard Thierry; Colombo Massimo; Bruix Jordi; Schiff Eugene; Terg Ruben; Flamm Steven; Moreno-Otero Ricardo; Carrilho Flair; Schmidt Warren; Berg Thomas; McGarrity Thomas; Heathcote E Jenny; Gonçales Fernando; Diago Moises; Craxi Antonio; Silva Marcelo; Bedossa Pierre; Mukhopadhyay Pabak; Griffel Louis; Burroughs Margaret; Brass Clifford; Albrecht Janice;
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Gastroenterology 2009;136(5):1618-28.e2.
-
2009: Poynard Thierry; Ratziu Vlad
Prolonged therapy for hepatitis C with low-dose peginterferon.
The New England journal of medicine 2009;360(11):1152; author reply 1152-3.
-
2009: Vanlemmens Claire; Di Martino Vincent; Milan Chantal; Messner Michel; Minello Anne; Duvoux Christophe; Poynard Thierry; Perarnau Jean-Marc; Piquet Marie-Anne Astrid; Pageaux Georges-Philippe; Dharancy Sébastien; Silvain Christine; Hillaire Sophie; Thiefin Gérard; Vinel Jean-Pierre; Hillon Patrick; Collin Estelle; Mantion Georges; Miguet Jean-Philippe;
Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.
Annals of internal medicine 2009;150(3):153-61.
-
2009: Ingiliz Patrick; Valantin Marc-Antoine; Duvivier Claudine; Medja Fadia; Dominguez Stephanie; Charlotte Frédéric; Tubiana Roland; Poynard Thierry; Katlama Christine; Lombès Anne; Benhamou Yves
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
Hepatology (Baltimore, Md.) 2009;49(2):436-42.
-
2009: Naveau Sylvie; Gaudé Guillaume; Asnacios Amani; Agostini Hélène; Abella Annie; Barri-Ova Nadège; Dauvois Barbara; Prévot Sophie; Ngo Yen; Munteanu Mona; Balian Axel; Njiké-Nakseu Micheline; Perlemuter Gabriel; Poynard Thierry
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Hepatology (Baltimore, Md.) 2009;49(1):97-105.
-
2009: Imbert-Bismut Françoise; Naveau Sylvie; Morra Rachel; Munteanu Mona; Ratziu Vlad; Abella Annie; Messous Djamila; Thabut Dominique; Benhamou Yves; Poynard Thierry
The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.
European journal of gastroenterology & hepatology 2009;21(1):18-27.
-
2008: Lebray Pascal; Varnous Shaïda; Charlotte Fréderic; Varaut Anne; Poynard Thierry; Ratziu Vlad
Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency.
Hepatology (Baltimore, Md.) 2008;48(6):2089.
-
2008: Poynard Thierry; Morra Rachel; Ingiliz Patrick; Imbert-Bismut Françoise; Thabut Dominique; Messous Djamila; Munteanu Mona; Massard Julien; Benhamou Yves; Ratziu Vlad
Assessment of liver fibrosis: noninvasive means.
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2008;14(4):163-73.
-
2008: Halfon Philippe; Munteanu Mona; Poynard Thierry
FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Gastroentérologie clinique et biologique 2008;32(6 Suppl 1):22-39.
-
2008: Munteanu Mona; Imbert-Bismut Françoise; Messous Djamila; Morra Rachel; Thabut Dominique; Lebray Pascal; Benhamou Yves; Ratziu Vlad; Poynard Thierry
Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
Clinical biochemistry 2008;41(13):1113-4.
-
2008: Jacqueminet Sophie; Lebray Pascal; Morra Rachel; Munteanu Mona; Devers Laure; Messous Djamila; Bernard Maguy; Hartemann-Heurtier Agnes; Imbert-Bismut Francoise; Ratziu Vlad; Grimaldi Andre; Poynard Thierry
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(7):828-31.
-
2008: Ratziu Vlad; Giral Philippe; Jacqueminet Sophie; Charlotte Fréderic; Hartemann-Heurtier Agnès; Serfaty Lawrence; Podevin Philippe; Lacorte Jean-Marc; Bernhardt Carole; Bruckert Eric; Grimaldi André; Poynard Thierry;
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.
Gastroenterology 2008;135(1):100-10.
-
2008: Munteanu Mona; Ratziu Vlad; Morra Rachel; Messous Djamila; Imbert-Bismut Francoise; Poynard Thierry
Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Journal of gastrointestinal and liver diseases : JGLD 2008;17(2):187-91.
-
2008: Asnacios Amani; Fartoux Laetitia; Romano Olivier; Tesmoingt Chloe; Louafi S Samy; Mansoubakht Touraj; Artru Pascal; Poynard Thierry; Rosmorduc Olivier; Hebbar Mohamed; Taieb Julien
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.
Cancer 2008;112(12):2733-9.
-
2008: Friedrich-Rust Mireen; Koch Constanze; Rentzsch Axel; Sarrazin Christoph; Schwarz Peter; Herrmann Eva; Lindinger Angelika; Sarrazin Ulrike; Poynard Thierry; Schäfers Hans-Joachim; Zeuzem Stefan; Abdul-Khaliq Hashim
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
The Journal of thoracic and cardiovascular surgery 2008;135(3):560-7.
-
2008: Morra Rachel; Lebray Pascal; Ingiliz Patrick; Ngo Yen; Munteanu Mona; Ratziu Vlad; Poynard Thierry
FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2008;47(1):353-4; author reply 354-6.
-
2008: Malamut Georgia; Ziol Marianne; Suarez Felipe; Beaugrand Michel; Viallard Jean François; Lascaux Anne Sophie; Verkarre Virginie; Bechade Dominique; Poynard Thierry; Hermine Olivier; Cellier Christophe
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Journal of hepatology 2008;48(1):74-82.
-
2008: Poynard Thierry; Ingiliz Patrick; Elkrief Laure; Munteanu Mona; Lebray Pascal; Morra Rachel; Messous Djamila; Bismut Francoise Imbert; Roulot Dominique; Benhamou Yves; Thabut Dominique; Ratziu Vlad
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.
PloS one 2008;3(12):e3857.
-
2008: Ingiliz Patrick; Valantin Marc-Antoine; Thibault Vincent; Duvivier Claudine; Dominguez Stephanie; Katlama Christine; Poynard Thierry; Benhamou Yves
Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.
Antiviral therapy 2008;13(7):895-900.
-
2008: Poynard Thierry; Morra Rachel; Ingiliz Patrick; Imbert-Bismut Françoise; Thabut Dominique; Messous Djamila; Munteanu Mona; Massard Julien; Benhamou Yves; Ratziu Vlad
Biomarkers of liver fibrosis.
Advances in clinical chemistry 2008;46():131-60.
-
2008: Ngo Yen; Benhamou Yves; Thibault Vincent; Ingiliz Patrick; Munteanu Mona; Lebray Pascal; Thabut Dominique; Morra Rachel; Messous Djamila; Charlotte Frederic; Imbert-Bismut Françoise; Bonnefont-Rousselot Dominique; Moussalli Joseph; Ratziu Vlad; Poynard Thierry
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
PloS one 2008;3(7):e2573.
-
2007: Thabut Dominique; Massard Julien; Gangloff Alice; Carbonell Nicolas; Francoz Claire; Nguyen-Khac Eric; Duhamel Christian; Lebrec Didier; Poynard Thierry; Moreau Richard
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.
Hepatology (Baltimore, Md.) 2007;46(6):1872-82.
-
2007: Thabut Dominique; Tazi Khalid A; Bonnefont-Rousselot Dominique; Aller Maria; Farges Olivier; Guimont Marie-Christine; Tellier Zera; Guichard Cecile; Ogier-Denis Eric; Poynard Thierry; Moreau Richard; Lebrec Didier
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
Hepatology (Baltimore, Md.) 2007;46(6):1893-906.
-
2007: Rosenthal-Allieri Maria Alessandra; Tran Albert; Halfon Philippe; Imbert-Bismut Françoise; Munteanu Mona; Messous Djamila; Peritore Marie-Line; Poynard Thierry; Bernard Alain
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Gastroentérologie clinique et biologique 2007;31(10):815-21.
-
2007: Morra Rachel; Munteanu Mona; Imbert-Bismut Françoise; Messous Djamila; Ratziu Vlad; Poynard Thierry
FibroMAX: towards a new universal biomarker of liver disease?
Expert review of molecular diagnostics 2007;7(5):481-90.
-
2007: Morra R; Munteanu M; Bedossa P; Dargere D; Janneau J-L; Paradis V; Ratziu V; Charlotte F; Thibault V; Imbert-Bismut F; Poynard T
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
Alimentary pharmacology & therapeutics 2007;26(6):847-58.
-
2007: Poynard Thierry; Halfon Philippe; Castera Laurent; Munteanu Mona; Imbert-Bismut Françoise; Ratziu Vlad; Benhamou Yves; Bourlière Marc; de Ledinghen Victor;
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.
Clinical chemistry 2007;53(9):1615-22.
-
2007: Zarski Jean-Pierre; Bedossa Pierre; Bronowicki Jean-Pierre; Doffoel Michel; Poynard Thierry
[Non invasive markers using for the assessment of fibrosis in hepatitis C]
Gastroentérologie clinique et biologique 2007;31(8-9 Pt 3):4S34-9.
-
2007: Thabut D; Imbert-Bismut F; Cazals-Hatem D; Messous D; Muntenau M; Valla D C; Moreau R; Poynard T; Lebrec D
Relationship between the Fibrotest and portal hypertension in patients with liver disease.
Alimentary pharmacology & therapeutics 2007;26(3):359-68.
-
2007: Myers Robert P; Messous Djamila; Poynard Thierry; Imbert-Bismut Francoise
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2007;21(5):289-94.
-
2007: Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
Alimentary pharmacology & therapeutics 2007;25(8):949-54.
-
2007: Louafi Samy; Boige Valérie; Ducreux Michel; Bonyhay Luminita; Mansourbakht Touraj; de Baere Thierry; Asnacios Amani; Hannoun Laurent; Poynard Thierry; Taïeb Julien
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.
Cancer 2007;109(7):1384-90.
-
2007: Fartoux Laetitia; Degos Françoise; Trépo Christian; Goria Odile; Calès Paul; Tran Albert; Buffet Catherine; Poynard Thierry; Capron Dominique; Raabe Jean-Jacques; Roulot Dominique; Naveau Sylvie; Grange Jean-Didier; Poupon Renée E; Poupon Raoul; Serfaty Lawrence
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(4):502-7.
-
2007: Ratziu Vlad; Vispo Maria; Tahiri Mohamed; Bonyhay Luminita; de Torres Mercedes; Bernhardt Carole; Poynard Thierry; Lebray Pascal
[Can metabolic steatohepatitis be treated?]
Gastroentérologie clinique et biologique 2007;31(3):333-40.
-
2007: Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
Alimentary pharmacology & therapeutics 2007;25(6):733-9.
-
2007: Deuffic-Burban S; Poynard T; Sulkowski M S; Wong J B
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
Journal of viral hepatitis 2007;14(2):107-15.
-
2007: Ratziu V; Giral P; Munteanu M; Messous D; Mercadier A; Bernard M; Morra R; Imbert-Bismut F; Bruckert E; Poynard T
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.
Alimentary pharmacology & therapeutics 2007;25(2):207-18.
-
2007: Poynard Thierry; Morra Rachel; Halfon Philippe; Castera Laurent; Ratziu Vlad; Imbert-Bismut Françoise; Naveau Sylvie; Thabut Dominique; Lebrec Didier; Zoulim Fabien; Bourliere Marc; Cacoub Patrice; Messous Djamila; Munteanu Mona; de Ledinghen Victor
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
BMC gastroenterology 2007;7():40.
-
2007: Prodanovic Hélène; Cracco Christophe; Massard Julien; Barrault Camille; Thabut Dominique; Duguet Alexandre; Datry Annick; Derenne Jean-Philippe; Poynard Thierry; Similowski Thomas
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series.
BMC gastroenterology 2007;7():2.
-
2006: Abel Michal; Sène Damien; Pol Stanislas; Bourlière Marc; Poynard Thierry; Charlotte Frédéric; Cacoub Patrice; Caillat-Zucman Sophie
Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2006;44(6):1607-16.
-
2006: Ratziu Vlad; Poynard Thierry
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.
Hepatology (Baltimore, Md.) 2006;44(4):802-5.
-
2006: McHutchison John; Poynard Thierry; Afdhal Nezam;
Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(10):1214-1220.
-
2006: Ngo Yen; Munteanu Mona; Messous Djamila; Charlotte Frederic; Imbert-Bismut Françoise; Thabut Dominique; Lebray Pascal; Thibault Vincent; Benhamou Yves; Moussalli Joseph; Ratziu Vlad; Poynard Thierry
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
Clinical chemistry 2006;52(10):1887-96.
-
2006: Sène Damien; Limal Nicholas; Messous Djamila; Ghillani-Dalbin Pascale; Charlotte Frédéric; Thiollière Jean-Marie; Piette Jean-Charles; Imbert-Bismut Françoise; Halfon Philippe; Poynard Thierry; Cacoub Patrice
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
Clinical biochemistry 2006;39(7):715-21.
-
2006: Thabut Dominique; Le Calvez Sophie; Thibault Vincent; Massard Julien; Munteanu Mona; Di Martino Vincent; Ratziu Vlad; Poynard Thierry
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?
The American journal of gastroenterology 2006;101(6):1260-7.
-
2006: Avettand-Fenoel V; Thabut D; Katlama C; Poynard T; Thibault V
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
Journal of clinical microbiology 2006;44(6):2250-3.
-
2006: Thabut Dominique; Naveau Sylvie; Charlotte Frederic; Massard Julien; Ratziu Vlad; Imbert-Bismut Françoise; Cazals-Hatem Dominique; Abella Annie; Messous Djamila; Beuzen Fabienne; Munteanu Mona; Taieb Julien; Moreau Richard; Lebrec Didier; Poynard Thierry
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
Journal of hepatology 2006;44(6):1175-85.
-
2006: Halfon P; Bourlière M; Pol S; Benhamou Y; Ouzan D; Rotily M; Khiri H; Renou C; Pénaranda G; Saadoun D; Thibault V; Serpaggi J; Varastet M; Tainturier M-H; Poynard T; Cacoub P
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.
Journal of viral hepatitis 2006;13(5):329-35.
-
2006: Zoulim F; Poynard T; Degos F; Slama A; El Hasnaoui A; Blin P; Mercier F; Deny P; Landais P; Parvaz P; Trepo C;
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.
Journal of viral hepatitis 2006;13(4):278-88.
-
2006: Thabut Dominique; Trabut Jean-Baptiste; Massard Julien; Rudler Marika; Muntenau Mona; Messous Djamila; Poynard Thierry
Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(3):271-8.
-
2006: Lada Olivier; Benhamou Yves; Poynard Thierry; Thibault Vincent
Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.
Journal of virology 2006;80(6):2968-75.
-
2006: d'Arondel C; Munteanu M; Moussalli J; Thibault V; Naveau S; Simon A; Messous D; Morra R; Blot C; Poynard T
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers.
Journal of viral hepatitis 2006;13(3):182-9.
-
2006: Boige Valérie; Taïeb Julien; Hebbar Mohamed; Malka David; Debaere Thierry; Hannoun Laurent; Magherini Emmanuelle; Mignard Dominique; Poynard Thierry; Ducreux Michel
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level.
European journal of cancer (Oxford, England : 1990) 2006;42(4):456-9.
-
2006: Izzedine Hassane; Massard Julien; Poynard Thierry; Deray Gilbert
Lamivudine and HBV-associated nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(3):828-9.
-
2006: Amouretti Michel; Le Pen Claude; Gaudin Anne-Françoise; Bommelaer Gilles; Frexinos Jacques; Ruszniewski Philippe; Poynard Thierry; Maurel Frédérique; Priol Gaël; El Hasnaoui Abdelkader
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).
Gastroentérologie clinique et biologique 2006;30(2):241-6.
-
2006: Taieb Julien; Chaput Nathalie; Ménard Cédric; Apetoh Lionel; Ullrich Evelyn; Bonmort Mathieu; Péquignot Marie; Casares Noelia; Terme Magali; Flament Caroline; Opolon Paule; Lecluse Yann; Métivier Didier; Tomasello Elena; Vivier Eric; Ghiringhelli François; Martin François; Klatzmann David; Poynard Thierry; Tursz Thomas; Raposo Graça; Yagita Hideo; Ryffel Bernard; Kroemer Guido; Zitvogel Laurence
A novel dendritic cell subset involved in tumor immunosurveillance.
Nature medicine 2006;12(2):214-9.
-
2006: Poynard Thierry; Munteanu Mona; Ngo Yen; Torres Mercedes; Benhamou Yves; Thabut Dominique; Ratziu Vlad
Diagnostic value of FibroTest with normal serum aminotransferases.
Hepatology (Baltimore, Md.) 2006;43(2):374-5; author reply 375-6.
-
2006: Benhamou Yves; Thibault Vincent; Vig Pamela; Calvez Vincent; Marcelin Anne-Genevieve; Fievet Marie-Hélène; Currie Graeme; Chang Chuy G; Biao Lu; Xiong Shelly; Brosgart Carol; Poynard Thierry
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Journal of hepatology 2006;44(1):62-7.
-
2006: Poynard Thierry; Ratziu Vlad; Charlotte Frederic; Messous Djamila; Munteanu Mona; Imbert-Bismut Françoise; Massard Julien; Bonyhay Luninita; Tahiri Mohamed; Thabut Dominique; Cadranel Jean François; Le Bail Brigitte; de Ledinghen Victor;
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
BMC gastroenterology 2006;6():34.
-
2006: Férard Georges; Piton Annie; Messous Djamila; Imbert-Bismut Françoise; Frairi Asmaa; Poynard Thierry; Lessinger Jean-Marc
Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(4):400-6.
-
2006: Ratziu Vlad; Massard Julien; Charlotte Frederic; Messous Djamila; Imbert-Bismut Françoise; Bonyhay Luninita; Tahiri Mohamed; Munteanu Mona; Thabut Dominique; Cadranel Jean François; Le Bail Brigitte; de Ledinghen Victor; Poynard Thierry;
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
BMC gastroenterology 2006;6():6.
-
2006: Ratziu Vlad; Thibault Vincent; Benhamou Yves; Poynard Thierry
Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.
Comparative hepatology 2006;5():1.
-
2006: Massard Julien; Ratziu Vlad; Thabut Dominique; Moussalli Joseph; Lebray Pascal; Benhamou Yves; Poynard Thierry
Natural history and predictors of disease severity in chronic hepatitis C.
Journal of hepatology 2006;44(1 Suppl):S19-24.
-
2005: Ratziu V; Heurtier A; Bonyhay L; Poynard T; Giral P
Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.
Alimentary pharmacology & therapeutics 2005;22 Suppl 2():56-60.
-
2005: Chang Ting-Tsung; Gish Robert G; Hadziyannis Stephanos J; Cianciara Janusz; Rizzetto Mario; Schiff Eugene R; Pastore Giuseppe; Bacon Bruce R; Poynard Thierry; Joshi Shobha; Klesczewski Kenneth S; Thiry Alexandra; Rose Ronald E; Colonno Richard J; Hindes Robert G;
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.
Gastroenterology 2005;129(4):1198-209.
-
2005: McIlroy Dorian; Théodorou Ioannis; Ratziu Vlad; Vidaud Dominique; Pellet Philippe; Debré Patrice; Poynard Thierry
FAS promoter polymorphisms correlate with activity grade in hepatitis C patients.
European journal of gastroenterology & hepatology 2005;17(10):1081-8.
-
2005: Poynard Thierry; Zoulim Fabien; Ratziu Vlad; Degos Françoise; Imbert-Bismut Francoise; Deny Paul; Landais Paul; El Hasnaoui Abdelkader; Slama Alain; Blin Patrick; Thibault Vincent; Parvaz Parviz; Munteanu Mona; Trepo Christian
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
The American journal of gastroenterology 2005;100(9):1970-80.
-
2005: Lai Ching-Lung; Leung Nancy; Teo Eng-Kiong; Tong Myron; Wong Florence; Hann Hie-Won; Han Steven; Poynard Thierry; Myers Maureen; Chao George; Lloyd Deborah; Brown Nathaniel A;
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
Gastroenterology 2005;129(2):528-36.
-
2005: Piton A; Messous D; Imbert-Bismut F; Bergès J; Munteanu M; Poynard T; Hainque B
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]
Annales de biologie clinique 2005;63(4):385-95.
-
2005: Ratziu Vlad; Charlotte Frédéric; Heurtier Agnès; Gombert Sophie; Giral Philippe; Bruckert Eric; Grimaldi André; Capron Frédérique; Poynard Thierry;
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Gastroenterology 2005;128(7):1898-906.
-
2005: Imbert-Bismut F; Messous D; Raoult A; Poynard T; Bertrand J J; Marie P A; Louis V; Audy C; Thouy J M; Hainque B; Piton A
[Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest]
Annales de biologie clinique 2005;63(3):305-13.
-
2005: Poynard Thierry; Ratziu Vlad; Benhamou Yves; Thabut Dominique; Moussalli Joseph
Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?
Gastroenterology 2005;128(4):1146-8; author reply 1148.
-
2005: Naveau Sylvie; Raynard Bruno; Ratziu Vlad; Abella Annie; Imbert-Bismut Françoise; Messous Djamila; Beuzen Fabienne; Capron Frédérique; Thabut Dominique; Munteanu Mona; Chaput Jean Claude; Poynard Thierry
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(2):167-74.
-
2005: Poynard Thierry; Ratziu Vlad; Kim Ngo; Deuffic-Burban Sylvie
Age and gender will survive to competing risks as fibrosis factors.
Gastroenterology 2005;128(2):519-20; author reply 520-1.
-
2005: Poynard Thierry; Imbert-Bismut Francoise; Munteanu Mona; Ratziu Vlad
Diagnosis and treatment of viral liver fibrosis.
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2005;11(1):1-19.
-
2005: Poynard Thierry; Imbert-Bismut Françoise; Munteanu Mona; Ratziu Vlad
FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
Expert review of molecular diagnostics 2005;5(1):15-21.
-
2005: Ratziu Vlad; Poynard Thierry
NASH: a hidden and silent fibroser finally revealed?
Journal of hepatology 2005;42(1):12-4.
-
2005: Poynard Thierry; Ratziu Vlad; Naveau Sylvie; Thabut Dominique; Charlotte Frederic; Messous Djamila; Capron Dominique; Abella Annie; Massard Julien; Ngo Yen; Munteanu Mona; Mercadier Anne; Manns Michael; Albrecht Janice
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.
Comparative hepatology 2005;4():10.
-
2005: Férard Georges; Imbert-Bismut Françoise; Messous Djamila; Piton Annie; Ueda Shigeru; Poynard Thierry; Lessinger Jean-Marc
A reference material for traceability of aspartate aminotransferase (AST) results.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(5):549-53.
-
2004: Ratziu Vlad; Poynard Thierry
Long-term outcome improvement in patients with chronic hepatitis D treated with interferon alpha.
Nature clinical practice. Gastroenterology & hepatology 2004;1(2):76-7.
-
2004: Di Martino Vincent; Lebray Pascal; Myers Robert P; Pannier Emmanuelle; Paradis Valérie; Charlotte Frédéric; Moussalli Joseph; Thabut Dominique; Buffet Catherine; Poynard Thierry
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.
Hepatology (Baltimore, Md.) 2004;40(6):1426-33.
-
2004: Poynard Thierry
Treatment of cirrhotic patients in the pegylated interferon era.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36 Suppl 3():S344-8.
-
2004: Thabut Dominique; Thibault Vincent; Bernard-Chabert Brigitte; Mouquet Catherine; Di Martino Vincent; Le Calvez Sophie; Opolon Pierre; Benhamou Yves; Bitker Marc Olivier; Poynard Thierry
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.
European journal of gastroenterology & hepatology 2004;16(12):1367-73.
-
2004: Vallat Laurent; Benhamou Yves; Gutierrez Maya; Ghillani Pascale; Hercher Christel; Thibault Vincent; Charlotte Frédéric; Piette Jean-Charles; Poynard Thierry; Merle-Béral Hélène; Davi Frédéric; Cacoub Patrice
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.
Arthritis and rheumatism 2004;50(11):3668-78.
-
2004: Sene Damien; Ghillani-Dalbin Pascale; Thibault Vincent; Guis Laurence; Musset Lucile; Duhaut Pierre; Poynard Thierry; Piette Jean-Charles; Cacoub Patrice
Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
The Journal of rheumatology 2004;31(11):2199-206.
-
2004: Poynard Thierry
[The Fibrotest is an ethical choice because it is a cost-effective and anti-inflationistic test. Response to Jean Louis Payen and Jean Marie Combis]
Gastroentérologie clinique et biologique 2004;28(10 Pt 1):929-31.
-
2004: Poynard Thierry; Munteanu Mona; Imbert-Bismut Françoise; Charlotte Frederic; Thabut Dominique; Le Calvez Sophie; Messous Djamila; Thibault Vincent; Benhamou Yves; Moussalli Joseph; Ratziu Vlad
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.
Clinical chemistry 2004;50(8):1344-55.
-
2004: Lada Olivier; Benhamou Yves; Cahour Annie; Katlama Christine; Poynard Thierry; Thibault Vincent
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Antiviral therapy 2004;9(3):353-63.
-
2004: Bommelaer Gilles; Poynard Thierry; Le Pen Claude; Gaudin Anne-Françoise; Maurel Frédérique; Priol Gaël; Amouretti Michel; Frexinos Jacques; Ruszniewski Philippe; El Hasnaoui Abdelkader
Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.
Gastroentérologie clinique et biologique 2004;28(6-7 Pt 1):554-61.
-
2004: Thabut D; Ratziu V; Trabut J-B; Poynard T
Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone.
Gut 2004;53(6):913-4; author reply 914-5.
-
2004: Le Pen C; Ruszniewski P; Gaudin A F; Amouretti M; Bommelaer G; Frexinos J; Poynard T; Maurel F; Priol G; Bertin C
The burden cost of French patients suffering from irritable bowel syndrome.
Scandinavian journal of gastroenterology 2004;39(4):336-43.
-
2004: Ratziu Vlad; Imbert-Bismut Françoise; Messous Djamila; Poynard Thierry
The elusiveness of "normal" ALT in fatty liver.
Hepatology (Baltimore, Md.) 2004;39(4):1172; author reply 1173.
-
2004: Imbert-Bismut Françoise; Messous Djamila; Thibault Vincent; Myers Rob B; Piton Annie; Thabut Dominique; Devers Laure; Hainque Bernard; Mercadier Anne; Poynard Thierry
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(3):323-33.
-
2004: Le Calvez Sophie; Thabut Dominique; Messous Djamila; Munteanu Mona; Ratziu Vlad; Imbert-Bismut Francoise; Poynard Thierry
The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2004;39(3):862-3; author reply 863.
-
2004: Deuffic-Burban Sylvie; Wong John B; Valleron Alain-Jacques; Costagliola Dominique; Delfraissy Jean-François; Poynard Thierry
Comparing the public health burden of chronic hepatitis C and HIV infection in France.
Journal of hepatology 2004;40(2):319-26.
-
2004: Hannon Heidi; Bagnis Corinne Isnard; Benhamou Yves; Beaufils Hélène; Sullivan Mark; Brosgart Carol; Izzedine Hassan; Poynard Thierry; Deray Gilbert
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):386-90.
-
2004: Ratziu Vlad; Trabut Jean-Baptiste; Poynard Thierry
Fat, diabetes, and liver injury in chronic hepatitis C.
Current gastroenterology reports 2004;6(1):22-9.
-
2004: Alatrakchi Nadia; Di Martino Vincent; Thibault Vincent; Benhamou Yves; Katlama Christine; Poynard Thierry; Autran Brigitte
Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection.
AIDS (London, England) 2004;18(1):121-3.
-
2004: Myers Robert P; Benhamou Yves; Bochet Marie; Thibault Vincent; Mehri Delphine; Poynard Thierry
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
AIDS (London, England) 2004;18(1):75-9.
-
2004: Poynard Thierry
Treatment of hepatitis C virus: the first decade.
Seminars in liver disease 2004;24 Suppl 2():19-24.
-
2003: Poynard Thierry; Yuen Man-Fung; Ratziu Vlad; Lai Ching Lung
Viral hepatitis C.
Lancet 2003;362(9401):2095-100.
-
2003: Lai Ching Lung; Ratziu Vlad; Yuen Man-Fung; Poynard Thierry
Viral hepatitis B.
Lancet 2003;362(9401):2089-94.
-
2003: Taïeb Julien; Bonyhay Luminita; Golli Lamia; Ducreux Michel; Boleslawski Emmanuel; Tigaud Jean-Marie; de Baere Thierry; Mansourbakht Touraj; Delgado Marie Anna; Hannoun Laureut; Poynard Thierry; Boige Valerie
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
Cancer 2003;98(12):2664-70.
-
2003: Ratziu Vlad; Munteanu Mona; Charlotte Fréderic; Bonyhay Luminita; Poynard Thierry;
Fibrogenic impact of high serum glucose in chronic hepatitis C.
Journal of hepatology 2003;39(6):1049-55.
-
2003: Ratziu Vlad; Le Calvez Sophie; Bonyhay Luminita; Taieb Julien; Poynard Thierry
[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?]
Gastroentérologie clinique et biologique 2003;27(10):869-75.
-
2003: Poynard Thierry
[Should we have the courage to say no to systematic liver biopsy?]
Gastroentérologie clinique et biologique 2003;27(8-9):844-6; author reply 846.
-
2003: Ratziu Vlad; Poynard Thierry
[Non-alcoholic steatosis: limits of current knowledge and lessons for hepatologists]
Gastroentérologie clinique et biologique 2003;27(8-9):715-7.
-
2003: Poynard Thierry; McHutchison John; Manns Michael; Myers Rob P; Albrecht Janice
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.
Hepatology (Baltimore, Md.) 2003;38(2):481-92.
-
2003: Myers Robert P; Tainturier Marie Hélène; Ratziu Vlad; Piton Annie; Thibault Vincent; Imbert-Bismut Françoise; Messous Djamila; Charlotte Frederic; Di Martino Vincent; Benhamou Yves; Poynard Thierry
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
Journal of hepatology 2003;39(2):222-30.
-
2003: Poynard Thierry; Ratziu Vlad; McHutchison John; Manns Michael; Goodman Zachary; Zeuzem Stefan; Younossi Zobair; Albrecht Janice
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.
Hepatology (Baltimore, Md.) 2003;38(1):75-85.
-
2003: Poynard T; Marcellin P; Bissery A; Myers R P; Moussalli J; Degos F; Dhumeaux D; Riachi G; Bronowicki J P; Brissot P; Buffet C; Serfaty L; Naveau S; Sogni P; Beaugrand M; Gayno S; Larrey D; Samuel D; Eugene C; Pol S; Bedossa P; Daurat V; Chaumet-Riffaud P;
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.
Journal of viral hepatitis 2003;10(3):197-204.
-
2003: Thabut Dominique; Simon Marion; Myers Robert P; Messous Djamila; Thibault Vincent; Imbert-Bismut Françoise; Poynard Thierry
Noninvasive prediction of fibrosis in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2003;37(5):1220-1; author reply 1221.
-
2003: Koretz Ronald L; Poynard Thierry
Truth is not determined by a majority vote.
Gastroenterology 2003;124(4):1153-5.
-
2003: Poynard Thierry; Thabut Dominique; Chryssostalis Ariane; Taieb Julien; Ratziu Vlad
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?
Journal of hepatology 2003;38(4):518-20.
-
2003: Thabut D; Ratziu V; Bernard-Chabert B; Poynard T; Benhamou Y; Thibault V
Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure.
Gut 2003;52(4):614.
-
2003: Myers Robert P; Benhamou Yves; Imbert-Bismut Françoise; Thibault Vincent; Bochet Marie; Charlotte Frédéric; Ratziu Vlad; Bricaire François; Katlama Christine; Poynard Thierry
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
AIDS (London, England) 2003;17(5):721-5.
-
2003: Myers R P; Thibault V; Poynard T
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.
Journal of viral hepatitis 2003;10(2):103-10.
-
2003: Poynard Thierry; Mathurin Philippe; Lai Ching-Lung; Guyader Dominique; Poupon Renée; Tainturier Marie-Hélène; Myers Robert P; Muntenau Mona; Ratziu Vlad; Manns Michael; Vogel Arndt; Capron Frédérique; Chedid Antonio; Bedossa Pierre;
A comparison of fibrosis progression in chronic liver diseases.
Journal of hepatology 2003;38(3):257-65.
-
2003: de Torres Mercedes; Poynard Thierry
Risk factors for liver fibrosis progression in patients with chronic hepatitis C.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2003;2(1):5-11.
-
2003: Myers Robert P; De Torres Mercedes; Imbert-Bismut Françoise; Ratziu Vlad; Charlotte Frédéric; Poynard Thierry;
Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.
Digestive diseases and sciences 2003;48(1):146-53.
-
2003: Golli Lamia; Taïeb Julien; Boleslawski Emmanuel; Charlotte Frédéric; Taboury Jacques; di Martino Vincent; Poynard Thierry; Hannoun Laurent
[Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis]
Gastroentérologie clinique et biologique 2003;27(1):127-9.
-
2003: Benhamou Yves; Poynard Thierry
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Journal of hepatology 2003;39 Suppl 1():S194-9.
-
2002: Colombat Magali; Charlotte Frédéric; Ratziu Vlad; Poynard Thierry
Portal lymphocytic infiltrate in alcoholic liver disease.
Human pathology 2002;33(12):1170-4.
-
2002: Taïeb Julien; Delarche Charlotte; Ethuin Fréderic; Selloum Saphia; Poynard Thierry; Gougerot-Pocidalo Marie-Anne; Chollet-Martin Sylvie
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils.
Journal of leukocyte biology 2002;72(6):1142-7.
-
2002: Ratziu Vlad; Nourani Maya; Poynard Thierry
Discussion on celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.
Gastroenterology 2002;123(6):2158-9; author reply 2159-60.
-
2002: Alric Laurent; Di-Martino Vincent; Selves Janik; Cacoub Patrice; Charlotte Frédéric; Reynaud Didier; Piette Jean-Charles; Péron Jean-Marie; Vinel Jean-Pierre; Durand Dominique; Izopet Jacques; Poynard Thierry; Duffaut Michel; Rostaing Lionel
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.
Gastroenterology 2002;123(5):1494-9.
-
2002: McHutchison John G; Manns Michael; Patel Keyur; Poynard Thierry; Lindsay Karen L; Trepo Christian; Dienstag Jules; Lee William M; Mak Carmen; Garaud Jean-Jacques; Albrecht Janice K;
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.
Gastroenterology 2002;123(4):1061-9.
-
2002: Pradat Pierre; Alberti Alfredo; Poynard Thierry; Esteban Juan-Ignacio; Weiland Ola; Marcellin Patrick; Badalamenti Salvatore; Trépo Christian
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.
Hepatology (Baltimore, Md.) 2002;36(4 Pt 1):973-7.
-
2002: Myers Robert P; Ratziu Vlad; Imbert-Bismut Françoise; Charlotte Frédéric; Poynard Thierry;
Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
The American journal of gastroenterology 2002;97(9):2419-25.
-
2002: Lebray Pascal; Benhamou Yves; Pol Stanislas; Myers Robert P; Poynard Thierry; Di Martino Vincent
NNRTI-related or -unrelated hepatotoxicity?
Hepatology (Baltimore, Md.) 2002;36(2):512-3; author reply 513-4.
-
2002: Poynard T; Cacoub P; Ratziu V; Myers R P; Dezailles M H; Mercadier A; Ghillani P; Charlotte F; Piette J C; Moussalli J;
Fatigue in patients with chronic hepatitis C.
Journal of viral hepatitis 2002;9(4):295-303.
-
2002: Poynard Thierry; Munteanu Mona; Ratziu Vlad; Benhamou Yves; Di Martino Vincent; Taieb Julien; Opolon Pierre
Truth survival in clinical research: an evidence-based requiem?
Annals of internal medicine 2002;136(12):888-95.
-
2002: Cacoub Patrice; Ratziu Vlad; Myers Robert P; Ghillani Pascale; Piette Jean Charles; Moussalli Joseph; Poynard Thierry;
Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.
Journal of hepatology 2002;36(6):812-8.
-
2002: Ratziu Vlad; Bonyhay Luminita; Di Martino Vincent; Charlotte Frederic; Cavallaro Lucas; Sayegh-Tainturier Marie-Hélène; Giral Philippe; Grimaldi André; Opolon Pierre; Poynard Thierry
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Hepatology (Baltimore, Md.) 2002;35(6):1485-93.
-
2002: Ratziu Vlad; Sayegh-Tainturier Marie-Hélène; Nourani Maya; Poynard Thierry
[Pre-C mutations of the HBV]
Gastroentérologie clinique et biologique 2002;26(5):509-13.
-
2002: Poynard Thierry; McHutchison John; Manns Michael; Trepo Christian; Lindsay Karen; Goodman Zachary; Ling Mei-Hsiu; Albrecht Janice
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
Gastroenterology 2002;122(5):1303-13.
-
2002: Myers Robert P; Regimbeau Corinne; Moussalli Joseph; Ratziu Vlad; Di Martino Vincent; Thabut Dominique; Bernard Brigitte; Benhamou Yves; Poynard Thierry
[What are the indications for treatment of acute hepatitis C?]
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B188-93.
-
2002: Poynard Thierry
Uses of error.
Lancet 2002;359(9316):1514.
-
2002: Dangles V; Lazar V; Validire P; Richon S; Wertheimer M; Laville V; Janneau J-L; Barrois M; Bovin C; Poynard T; Vallancien G; Bellet D
Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.
British journal of cancer 2002;86(8):1283-9.
-
2002: Mathurin Philippe; Mendenhall Charles L; Carithers Robert L; Ramond Marie-Jose; Maddrey Willis C; Garstide Peter; Rueff Bernard; Naveau Sylvie; Chaput Jean-Claude; Poynard Thierry
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Journal of hepatology 2002;36(4):480-7.
-
2002: Soriano Vincent; Sulkowski Mark; Bergin Colm; Hatzakis Angelos; Cacoub Patrice; Katlama Christine; Cargnel Antonietta; Mauss Stefan; Dieterich Douglas; Moreno Santiago; Ferrari Carlo; Poynard Thierry; Rockstroh Jürgen
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.
AIDS (London, England) 2002;16(6):813-28.
-
2002: Poynard T; Imbert-Bismut F; Ratziu V; Chevret S; Jardel C; Moussalli J; Messous D; Degos F;
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial.
Journal of viral hepatitis 2002;9(2):128-33.
-
2002: Deuffic-Burban S; Poynard T; Valleron A-J
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.
Journal of viral hepatitis 2002;9(2):114-22.
-
2002: Goulenok C; Bernard B; Cadranel J F; Thabut D; Di Martino V; Opolon P; Poynard T
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
Alimentary pharmacology & therapeutics 2002;16(3):361-72.
-
2002: McHutchison John G; Poynard Thierry; Esteban-Mur Rafael; Davis Gary L; Goodman Zachary D; Harvey Joann; Ling Mei-Hsiu; Garaud Jean Jacques; Albrecht Janice K; Patel Keyur; Dienstag Jules L; Morgan Timothy;
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
Hepatology (Baltimore, Md.) 2002;35(3):688-93.
-
2002: Taïeb Julien; Delarche Charlotte; Paradis Valérie; Mathurin Philippe; Grenier Alain; Crestani Bruno; Dehoux Monique; Thabut Dominique; Gougerot-Pocidalo Marie-Anne; Poynard Thierry; Chollet-Martin Sylvie
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis.
Journal of hepatology 2002;36(3):342-8.
-
2002: Halimi Chantal; Bonnard Philippe; Bernard Brigitte; Mathurin Philippe; Mofredj Ali; di Martino Vincent; Demontis Renato; Henry-Biabaud Edmond; Fievet Patrick; Opolon Pierre; Poynard Thierry; Cadranel Jean François
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
European journal of gastroenterology & hepatology 2002;14(2):153-8.
-
2002: Myers R P; Poynard T
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(4):CD003617.
-
2002: Myers R P; Regimbeau C; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski J P; Poynard T
Interferon for interferon naive patients with chronic hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(2):CD000370.
-
2002: Poynard T; Regimbeau C; Myers R P; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski J P
Interferon for acute hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(1):CD000369.
-
2001: Bommelaer G; Bruley Des Varannes S; Fléjou J F; Matysiak T; Poynard T; Richard A; Slama A; Mégraud F;
[CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study]
Gastroentérologie clinique et biologique 2001;25(12):1084-9.
-
2001: Thabut D; Thibault V; Benhamou Y; Bernard B; Aubron-Olivier C; Poynard T; Di Martino V
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
AIDS (London, England) 2001;15(18):2463-4.
-
2001: Pieroni L; Khalil L; Charlotte F; Poynard T; Piton A; Hainque B; Imbert-Bismut F
Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration.
Clinical chemistry 2001;47(11):2059-61.
-
2001: Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet M H; Vig P; Gibbs C S; Brosgart C; Fry J; Namini H; Katlama C; Poynard T
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Lancet 2001;358(9283):718-23.
-
2001: Benhamou Y; Di Martino V; Bochet M; Colombet G; Thibault V; Liou A; Katlama C; Poynard T;
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.
Hepatology (Baltimore, Md.) 2001;34(2):283-7.
-
2001: Poynard T; Ratziu V; Charlotte F; Goodman Z; McHutchison J; Albrecht J
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.
Journal of hepatology 2001;34(5):730-9.
-
2001: Poynard T; Regimbeau C; Benhamou Y
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.
Alimentary pharmacology & therapeutics 2001;15(3):355-61.
-
2001: Thévenot T; Regimbeau C; Ratziu V; Leroy V; Opolon P; Poynard T
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.
Journal of viral hepatitis 2001;8(1):48-62.
-
2000: Mouquet C; Bernard B; Poynard T; Thibault V; Opolon P; Coriat P; Bitker M O
Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
Transplantation proceedings 2000;32(8):2762.
-
2000: Poynard T; McHutchison J; Davis G L; Esteban-Mur R; Goodman Z; Bedossa P; Albrecht J
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;32(5):1131-7.
-
2000: Zylberberg H; Benhamou Y; Lagneaux J L; Landau A; Chaix M L; Fontaine H; Bochet M; Poynard T; Katlama C; Pialoux G; Bréchot C; Pol S
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.
Gut 2000;47(5):694-7.
-
2000: Wong J B; Poynard T; Ling M H; Albrecht J K; Pauker S G
Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
The American journal of gastroenterology 2000;95(6):1524-30.
-
2000: Poynard T; Ratziu V; Bedossa P
Appropriateness of liver biopsy.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000;14(6):543-8.
-
2000: Ratziu V; Giral P; Charlotte F; Bruckert E; Thibault V; Theodorou I; Khalil L; Turpin G; Opolon P; Poynard T
Liver fibrosis in overweight patients.
Gastroenterology 2000;118(6):1117-23.
-
2000: Poynard T; Ratziu V; Benhamou Y; Regimbeau C
[Treatment and prevention of hepatitis C]
La Revue du praticien 2000;50(10):1100-7.
-
2000: Poynard T; Ratziu V; Benhamou Y; Opolon P; Cacoub P; Bedossa P
Natural history of HCV infection.
Baillière's best practice & research. Clinical gastroenterology 2000;14(2):211-28.
-
2000: Allory Y; Charlotte F; Benhamou Y; Opolon P; Le Charpentier Y; Poynard T
Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.
Human pathology 2000;31(1):69-74.
-
2000: Poynard T; McHutchison J; Goodman Z; Ling M H; Albrecht J
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group.
Hepatology (Baltimore, Md.) 2000;31(1):211-8.
-
2000: Poynard T; Ratziu V; Benmanov Y; Di Martino V; Bedossa P; Opolon P
Fibrosis in patients with chronic hepatitis C: detection and significance.
Seminars in liver disease 2000;20(1):47-55.
-
1999: Poynard T; Moussalli J; Ratziu V; Regimbeau C; Opolon P
Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma.
Clinics in liver disease 1999;3(4):869-81.
-
1999: Benhamou Y; Bochet M; Thibault V; Di Martino V; Caumes E; Bricaire F; Opolon P; Katlama C; Poynard T
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
Hepatology (Baltimore, Md.) 1999;30(5):1302-6.
-
1999: Cacoub P; Poynard T; Ghillani P; Charlotte F; Olivi M; Piette J C; Opolon P
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Arthritis and rheumatism 1999;42(10):2204-12.
-
1999: Benhamou Y; Bochet M; Di Martino V; Charlotte F; Azria F; Coutellier A; Vidaud M; Bricaire F; Opolon P; Katlama C; Poynard T
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.
Hepatology (Baltimore, Md.) 1999;30(4):1054-8.
-
1999: Deuffic S; Poynard T; Valleron A J
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe.
Journal of viral hepatitis 1999;6(5):411-3.
-
1999: Poynard T; Daurat V; Chevret S; Moussalli J; Degos F; Bailly F; Borotto E; Buffet C; Bartolomei-Portal I; Richardet J P; Riachi G; Calmus Y; Bréchot C; Vidaud M; Olivi M; Bedossa P; Riffaud P C; Chastang C
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 group.
Journal of viral hepatitis 1999;6(5):381-6.
-
1999: Thibault V; Benhamou Y; Seguret C; Bochet M; Katlama C; Bricaire F; Opolon P; Poynard T; Agut H
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.
Journal of clinical microbiology 1999;37(9):3013-6.
-
1999: Imbert-Bismut F; Charlotte F; Turlin B; Khalil L; Piton A; Brissot P; Le Charpentier Y; Delattre J; Opolon P; Deugnier Y; Poynard T
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.
Journal of clinical pathology 1999;52(6):430-4.
-
1999: Poynard T; Naveau S; Doffoel M; Boudjema K; Vanlemmens C; Mantion G; Messner M; Launois B; Samuel D; Cherqui D; Pageaux G; Bernard P H; Calmus Y; Zarski J P; Miguet J P; Chaput J C
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group.
Journal of hepatology 1999;30(6):1130-7.
-
1999: Bernard B; Grangé J D; Khac E N; Amiot X; Opolon P; Poynard T
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
Hepatology (Baltimore, Md.) 1999;29(6):1655-61.
-
1999: Deuffic S; Buffat L; Poynard T; Valleron A J
Modeling the hepatitis C virus epidemic in France.
Hepatology (Baltimore, Md.) 1999;29(5):1596-601.
-
1999: Calès P; Castaing D; Grangé J D; Lebrec D; Lemoine O; Poynard T; Silvain C; Sogni P; Vinel J P; Vons C; Nouel O; Bourgeois N; Bernard B; Hadengue A
[Treatment of portal hypertension]
Gastroentérologie clinique et biologique 1999;23(3):353-4.
-
1999: Sobesky R; Mathurin P; Charlotte F; Moussalli J; Olivi M; Vidaud M; Ratziu V; Opolon P; Poynard T
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.
Gastroenterology 1999;116(2):378-86.
-
1999: Poynard T
[Role and limits of self-medication in the therapeutic strategy of gastroesophageal reflux in adults]
Gastroentérologie clinique et biologique 1999;23(1 Pt 2):S176-9.
-
1999: Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel J F; Bernard B; Opolon P; Coriat P; Bitker M O
Impact of hepatitis B and C virus on kidney transplantation outcome.
Hepatology (Baltimore, Md.) 1999;29(1):257-63.
-
1999: Poynard T; Moussali J; Ratziu V; Regimbeau C; Opolon P
Effects of interferon therapy in "non responder" patients with chronic hepatitis C.
Journal of hepatology 1999;31 Suppl 1():178-83.
-
1998: Mathurin P; Taïeb J; Poynard T
[Corticosteroid therapy in acute severe alcoholic hepatitis: the end of a controversy?]
Gastroentérologie clinique et biologique 1998;22(12):991-5.
-
1998: Poynard T; Moussalli J; Ratziu V; Thevenot T; Regimbeau C; Opolon P; Horsmans Y; Brenard R; Closon M; Fevery J; Hautekeete M
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie.
Acta gastro-enterologica Belgica 1998;61(4):431-7.
-
1998: Desramé J; Mathurin P; Rozov R; Sabaté J M; Poynard T; Opolon P; Denis J
[Isolated ascites revealing a hypothyroidism. Study of 2 cases]
Gastroentérologie clinique et biologique 1998;22(8-9):732-5.
-
1998: Bernard B; Grangé J D; Khac E N; Amiot X; Opolon P; Poynard T
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis.
Digestion 1998;59 Suppl 2():54-7.
-
1998: Cacoub P; Musset L; Hausfater P; Ghillani P; Fabiani F L; Charlotte F; Angevin E; Opolon P; Poynard T; Piette J C; Autran B
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
Clinical and experimental immunology 1998;113(1):48-54.
-
1998: Piton A; Poynard T; Imbert-Bismut F; Khalil L; Delattre J; Pelissier E; Sansonetti N; Opolon P
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.
Hepatology (Baltimore, Md.) 1998;27(5):1213-9.
-
1998: Mathurin P; Ganne-Carrié N; Poynard T; Trinchet J C
[Pro-inflammatory cytokines in the pathogenesis of alcoholic hepatitis]
Gastroentérologie clinique et biologique 1998;22(3):311-9.
-
1998: Mathurin P; Moussalli J; Cadranel J F; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux J M; Devergie B; Vidaud M; Opolon P; Poynard T
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Hepatology (Baltimore, Md.) 1998;27(3):868-72.
-
1998: Poynard T; Vernisse B; Agostini H
Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux.
Alimentary pharmacology & therapeutics 1998;12(2):159-65.
-
1998: Mathurin P; Rixe O; Carbonell N; Bernard B; Cluzel P; Bellin M F; Khayat D; Opolon P; Poynard T
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?
Alimentary pharmacology & therapeutics 1998;12(2):111-26.
-
1998: Deuffic S; Poynard T; Buffat L; Valleron A J
Trends in primary liver cancer.
Lancet 1998;351(9097):214-5.
-
1997: Cacoub P; Musset L; Amoura Z; Guilani P; Chabre H; Lunel F; Poynard T; Opolon P; Piette J C
Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.
The Journal of rheumatology 1997;24(11):2139-44.
-
1997: Paradis V; Kollinger M; Fabre M; Holstege A; Poynard T; Bedossa P
In situ detection of lipid peroxidation by-products in chronic liver diseases.
Hepatology (Baltimore, Md.) 1997;26(1):135-42.
-
1997: Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
Journal of clinical pathology 1997;50(5):401-6.
-
1997: Poynard T; Bedossa P
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups.
Journal of viral hepatitis 1997;4(3):199-208.
-
1997: Auperin A; Pignon J P; Poynard T
Review article: critical review of meta-analyses of randomized clinical trials in hepatogastroenterology.
Alimentary pharmacology & therapeutics 1997;11(2):215-25.
-
1997: Poynard T; Bedossa P; Opolon P
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Lancet 1997;349(9055):825-32.
-
1997: Bernard B; Lebrec D; Mathurin P; Opolon P; Poynard T
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
Journal of hepatology 1997;26(2):312-24.
-
1997: Bernard B; Lebrec D; Mathurin P; Opolon P; Poynard T
Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
Hepatology (Baltimore, Md.) 1997;25(1):63-70.
-
1997: Poynard T; Ottignon Y; Pauphilet C; Agostini H
[Evaluation by a randomized trial of the usefulness of endoscopy after treatment of a flare-up of non-severe esophagitis]
Gastroentérologie clinique et biologique 1997;21(6-7):497-502.
-
1997: Poynard T
[Should hepatitis C be treated? What are indications of treatment in acute hepatitis C?]
Gastroentérologie clinique et biologique 1997;21(1 Pt 2):S66-9.
-
1997: Tordjman G; Bernard B; Chigot J P; Poynard T; Opolon P
[Recurrent lower digestive hemorrhage in young adults: a surgical indication]
Gastroentérologie clinique et biologique 1997;21(3):217-8.
-
1996: Paradis V; Mathurin P; Laurent A; Charlotte F; Vidaud M; Poynard T; Hoang C; Opolon P; Bedossa P
Histological features predictive of liver fibrosis in chronic hepatitis C infection.
Journal of clinical pathology 1996;49(12):998-1004.
-
1996: Poynard T; Leroy V; Mathurin P; Cohard M; Opolon P; Zarski J P
Treatment of chronic hepatitis C by interferon for longer duration than six months.
Digestive diseases and sciences 1996;41(12 Suppl):99S-102S.
-
1996: Mathurin P; Cadranel J F; Bouraya D; Bronstein J A; Collot G; Devergie B; Poynard T; Opolon P
Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases.
European journal of gastroenterology & hepatology 1996;8(11):1129-31.
-
1996: Benhamou Y; Katlama C; Lunel F; Coutellier A; Dohin E; Hamm N; Tubiana R; Herson S; Poynard T; Opolon P
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
Annals of internal medicine 1996;125(9):705-12.
-
1996: Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski J P
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Hepatology (Baltimore, Md.) 1996;24(4):778-89.
-
1996: Bedossa P; Poynard T
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.
Hepatology (Baltimore, Md.) 1996;24(2):289-93.
-
1996: Paradis V; Laurent A; Mathurin P; Poynard T; Vidaud D; Vidaud M; Bedossa P
Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes.
Cellular and molecular biology (Noisy-le-Grand, France) 1996;42(4):525-34.
-
1996: Paradis V; Mathurin P; Ratziu V; Poynard T; Bedossa P
Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix.
Hepatology (Baltimore, Md.) 1996;23(5):1232-8.
-
1996: Mathurin P; Vidaud D; Vidaud M; Bedossa P; Paradis V; Ratziu V; Chaput J C; Poynard T
Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease.
Hepatology (Baltimore, Md.) 1996;23(1):44-51.
-
1995: Poynard T; Lemaire M; Agostini H
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
European journal of gastroenterology & hepatology 1995;7(7):661-5.
-
1995: Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen J L; Sajus M; Costa J M
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
The New England journal of medicine 1995;332(22):1457-62.
-
1995: Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux J M; Katlama C; Opolon P; Gentilini M
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
Lancet 1995;345(8946):396-7.
-
1995: Poynard T; Lonjon I; Mathurin P; Abella A; Musset D; Bedossa P; Aubert A; Naveau S; Chaput J C
Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AII.
Alcoholism, clinical and experimental research 1995;19(1):75-80.
-
1995: Poynard T; Bedossa P; Mathurin P; Ratziu V; Paradis V
Apolipoprotein A1 and hepatic fibrosis.
Journal of hepatology 1995;22(2 Suppl):107-10.
-
1994: Cohard M; Poynard T; Mathurin P; Zarski J P
Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.
Hepatology (Baltimore, Md.) 1994;20(6):1390-8.
-
1994: Naveau S; Poynard T; Benattar C; Bedossa P; Chaput J C
Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest.
Digestive diseases and sciences 1994;39(11):2426-32.
-
1994: Poynard T; Naveau S; Mory B; Chaput J C
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.
Alimentary pharmacology & therapeutics 1994;8(5):499-510.
-
1994: Poynard T; Barthelemy P; Fratte S; Boudjema K; Doffoel M; Vanlemmens C; Miguet J P; Mantion G; Messner M; Launois B
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls.
Lancet 1994;344(8921):502-7.
-
1994: Holstege A; Bedossa P; Poynard T; Kollinger M; Chaput J C; Houglum K; Chojkier M
Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis.
Hepatology (Baltimore, Md.) 1994;19(2):367-74.
-
1993: Poynard T
Relapse rate of patients after healing of oesophagitis--a prospective study of alginate as self-care treatment for 6 months. French Co-operative Study Group.
Alimentary pharmacology & therapeutics 1993;7(4):385-92.
-
1992: Naveau S; Barritault L; Zourabichvili O; Champagne C; Prieur G; Limoge A; Poynard T; Chaput J C
[Analgesic effect of transcutaneous cranial electrostimulation in patients treated by Nd:YAG laser for cancer of the rectum. A double-blind randomized trial]
Gastroentérologie clinique et biologique 1992;16(1):8-11.
-
1991: Naveau S; Bedossa P; Poynard T; Mory B; Chaput J C
Portal hypertensive colopathy. A new entity.
Digestive diseases and sciences 1991;36(12):1774-81.
-
1991: Poynard T; Aubert A; Lazizi Y; Bedossa P; Hamelin B; Terris B; Naveau S; Dubreuil P; Pillot J; Chaput J C
Independent risk factors for hepatocellular carcinoma in French drinkers.
Hepatology (Baltimore, Md.) 1991;13(5):896-901.
-
1991: Poynard T; Aubert A; Bedossa P; Abella A; Naveau S; Paraf F; Chaput J C
A simple biological index for detection of alcoholic liver disease in drinkers.
Gastroenterology 1991;100(5 Pt 1):1397-402.
-
1991: Naveau S; Perrier C; Mory B; Poynard T; Chaput J C
[Endoscopic hemostasis for hemorrhagic gastroduodenal ulcer. Meta-analysis of randomized clinical trials]
Gastroentérologie clinique et biologique 1991;15(8-9):580-7.
-
1991: Poynard T; Bedossa P; Mathurin P; Naveau S; Delfraissy J F; Lemaigre G; Chaput J C
Efficacy of long term recombinant interferon-alfa in patients with chronic hepatitis C. A clinical, biological, histological and immunohistological study.
Gastroentérologie clinique et biologique 1991;15(8-9):615-9.
-
1990: Poynard T; Bedossa P; Jais P; Abella A; Naveau S; Aubert A; Lemaigre G; Chaput J C
Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitis.
Pancreas 1990;5(5):519-23.
-
1990: Naveau S; Aubert A; Poynard T; Chaput J C
Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation.
Digestive diseases and sciences 1990;35(7):821-6.
-
1990: Pol S; Poynard T; Bedossa P; Naveau S; Aubert A; Chaput J C
Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis.
Alcoholism, clinical and experimental research 1990;14(2):250-4.
-
1990: Bedossa P; Poynard T; Bacci J; Naveau S; Lemaigre G; Chaput J C; Martin E
Expression of histocompatibility antigens and characterization of the lymphocyte infiltrate in hyperplastic polyps of the large bowel.
Human pathology 1990;21(3):319-24.
-
1990: Naveau S; Chiesa A; Poynard T; Chaput J C
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome.
Digestive diseases and sciences 1990;35(3):294-301.
-
1990: Poynard T
[Modesty, uncertainty and pragmatism]
Gastroentérologie clinique et biologique 1990;14(6-7):600.
-
1990: Poynard T; Klepping C; Audigier J C; Barthelemy C; Bel A; Delmont J; Fournet J; Gaucher P; Rachail M
Randomized double-blind clinical trial of aluminum phosphate versus ranitidine in the acute treatment of duodenal ulcer.
Digestion 1990;47(2):105-10.
-
1990: Naveau S; Mory B; Poynard T; Chaput J C
[Randomized therapeutic trials in intestinal functional disorders]
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):65C-73C.
-
1990: Mory B; Poynard T; Naveau S; Chaput J C
[Epidemiology and methodology of randomized therapeutic trials in patients with intestinal functional disorders]
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):58C-64C.
-
1990: Poynard T; Lemann M; Darmoni S J
[What to expect from expert systems for the diagnosis of functional bowel disorders]
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):45C-48C.
-
1990: Poynard T
[Short-term severity factors of digestive hemorrhage caused by portal hypertension in patients with cirrhosis]
Gastroentérologie clinique et biologique 1990;14(1 ( Pt 2)):21B-24B.
-
1990: Pateron D; Naveau S; Brivet F; Bedossa P; Poynard T; Chaput J C
[Acute tuberculous pancreatitis in a patient with acquired immunodeficiency syndrome]
Gastroentérologie clinique et biologique 1990;14(1):80-3.
-
1989: Bedossa P; Poynard T; Abella A; Aubert A; Pignon J P; Naveau S; Leluc R; Lemaigre G; Martin E D; Chaput J C
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients.
Alcoholism, clinical and experimental research 1989;13(6):829-33.
-
1989: Poynard T; Bedossa P; Naveau S; Lemaigre G; Martin E D; Chaput J C
Perisinusoidal cells (Ito-cells) enlargement in a family with myotonic dystrophy.
Liver 1989;9(5):276-8.
-
1989: Paraf F; Naveau S; Zourabichvili O; Poynard T; Chaput J C
Endoscopic laser therapy for duodenal villous adenoma.
Digestive diseases and sciences 1989;34(9):1466-7.
-
1989: Bedossa P; Poynard T; Abella A; Paraf F; Lemaigre G; Martin E
Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.
Archives of pathology & laboratory medicine 1989;113(7):777-80.
-
1989: Poynard T
[The liver under top protection?]
Gastroentérologie clinique et biologique 1989;13(6-7):542-3.
-
1989: Naveau S; Bedossa P; Mallet L; Turner L; Poynard T; Andréani T; Chaput J C
Successful ablation of a large fibrovascular polyp of the esophagus by endoscopic Nd:YAG laser therapy.
Gastrointestinal endoscopy 1989;35(3):254-6.
-
1989: Naveau S; Poynard T; Zourabichvili O; Poitrine A; Chaput J C
A randomized study of a coaxial fiber versus a naked fiber for endoscopic Nd:YAG laser therapy of esophageal and rectal tumors.
Gastrointestinal endoscopy 1989;35(3):201-6.
-
1989: Poynard T; Pignon J P; Mory B; Naveau S; Chaput J C
Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
Gastroentérologie clinique et biologique 1989;13(1 Pt 1):112B-115B.
-
1988: Poynard T; Aubert A; Naveau S; Lemman M; Chaput J C
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]
Gastroentérologie clinique et biologique 1988;12(12):899-905.
-
1988: Poynard T; Tournade J M; Alberola B; Pappo M
[Semiology of gastroduodenal ulcer proved by endoscopy: epidemiological analysis of 1,800 cases]
Gastroentérologie clinique et biologique 1988;12(8-9):596-603.
-
1988: Geffriaud C; Poynard T; Delfraissy J F; Bedossa P; Naveau S; Bourée P; Dubreuil P; Chaput J C
[Hepatic involvement in HIV 1 virus infection]
Gastroentérologie clinique et biologique 1988;12(5):465-72.
-
1988: Bedossa P; Poynard T; Naveau S; Martin E D; Agostini H; Chaput J C
Observer variation in assessment of liver biopsies of alcoholic patients.
Alcoholism, clinical and experimental research 1988;12(1):173-8.
-
1987: Pignon J P; Poynard T; Naveau S; Sebag G; Chaput J C
[Treatment of gastroesophageal reflux: analysis of randomized double-blind trials]
Gastroentérologie clinique et biologique 1987;11(10):668-80.
-
1987: Naveau S; Zourabichvili O; Poitrine A; Houdayer C; Poynard T; Chaput J C
[Palliative treatment of cancers of the esophagus and cardia with neodymium YAG laser: short-term results and multidimensional analysis of factors related to functional improvement and tumor destruction]
Gastroentérologie clinique et biologique 1987;11(5):364-70.
-
1986: Naveau S; Poynard T; Zourabichvili O; Poitrine A; Chaput J C
Gastric phytobezoar destruction by Nd:YAG laser therapy.
Gastrointestinal endoscopy 1986;32(6):430-1.
-
1986: Poynard T; Abella A; Pignon J P; Naveau S; Leluc R; Chaput J C
Apolipoprotein AI and alcoholic liver disease.
Hepatology (Baltimore, Md.) 1986;6(6):1391-5.
-
1986: Naveau S; Roulot D; Zourabichvili O; Poitrine A; Poynard T; Chaput J C
[Palliative treatment of adenocarcinoma of the rectum by Nd-YAG laser. Immediate and long-term results. Study of factors related to the initial destruction of the tumor]
Gastroentérologie clinique et biologique 1986;10(10):651-5.
-
1986: Pignon J P; Poynard T; Naveau S; Marteau P; Zourabichvili O; Chaput J C
[Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis]
Gastroentérologie clinique et biologique 1986;10(6-7):461-7.
-
1985: Naveau S; Poynard T; Abella A; Pignon J P; Poitrine A; Agostini H; Zourabichvili O; Chaput J C
Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients.
Hepatology (Baltimore, Md.) 1985;5(5):819-23.
-
1984: Poynard T; Zourabichvili O; Hilpert G; Naveau S; Poitrine A; Benatar C; Chaput J C
Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients.
Hepatology (Baltimore, Md.) 1984;4(2):324-7.
-
1983: Poynard T; Naveau S; Poitrine A; Lebourgeois P; Hilpert G; Chaput J C
Recurrent bleeding and propranolol?
Digestive diseases and sciences 1983;28(7):667.
-
1983: Poitrine A; Poynard T; Naveau S; Hilpert G; Chaput J C
[A new fatal case of hepatitis caused by clometacin]
Gastroentérologie clinique et biologique 1983;7(1):99.
Sign-in to see more
